These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 8728920

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Relation between DNA content in ovarian cystadenoma and its pathohistology].
    Sun ZC.
    Zhonghua Fu Chan Ke Za Zhi; 1993 Dec; 28(12):731-3, 760-1. PubMed ID: 8137645
    [Abstract] [Full Text] [Related]

  • 4. Association of decreased mitochondrial DNA content with ovarian cancer progression.
    Wang Y, Liu VW, Xue WC, Cheung AN, Ngan HY.
    Br J Cancer; 2006 Oct 23; 95(8):1087-91. PubMed ID: 17047655
    [Abstract] [Full Text] [Related]

  • 5. DNA content and morphological parameters in synovial sarcoma and synovioma.
    Lu C, Xia J, Yang M.
    Chin Med J (Engl); 1995 Oct 23; 108(10):760-3. PubMed ID: 8565662
    [Abstract] [Full Text] [Related]

  • 6. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL, Shen DH, Xue WC, Li Y, Yu YZ.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr 23; 42(4):227-32. PubMed ID: 17631760
    [Abstract] [Full Text] [Related]

  • 7. [Clinical and pathological features of borderline ovarian tumors].
    Li Y, Cui H, Shen DH, Zhao Y, Wei LH, Qian HN.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Feb 23; 38(2):81-4. PubMed ID: 12783693
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
    Mayr D, Hirschmann A, Löhrs U, Diebold J.
    Gynecol Oncol; 2006 Dec 23; 103(3):883-7. PubMed ID: 16806438
    [Abstract] [Full Text] [Related]

  • 12. Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma.
    Lassus H, Staff S, Leminen A, Isola J, Butzow R.
    Gynecol Oncol; 2011 Jan 23; 120(1):11-7. PubMed ID: 20937525
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Correlation of genetic instability of nm23H1 gene to clinicopathologic features of epithelial ovarian carcinoma].
    Yang YQ, Li JC.
    Ai Zheng; 2006 Jun 23; 25(6):713-7. PubMed ID: 16764766
    [Abstract] [Full Text] [Related]

  • 19. [Diagnosis and prognosis of ovarian epithelial tumor with morphometry].
    Yin TJ, Gu MJ.
    Ai Zheng; 2002 Jul 23; 21(7):781-4. PubMed ID: 12479107
    [Abstract] [Full Text] [Related]

  • 20. Flow cytometry and AgNORs in benign, borderline, and malignant mucinous and serous tumours of the ovary.
    Griffiths AP, Cross D, Kingston RE, Harkin P, Wells M, Quirke P.
    Int J Gynecol Pathol; 1993 Oct 23; 12(4):307-14. PubMed ID: 8253547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.